Beyond the Bottom Line cover art

Beyond the Bottom Line

Beyond the Bottom Line

Written by: Panacea Healthcare Solutions
Listen for free

LIMITED TIME OFFER | Get 2 Months for ₹5/month

About this listen

 Welcome to Panacea’s podcast Beyond the Bottom Line: Let’s talk healthcare, finance, revenue cycle and compliance. Hosted by, Kevin Chmura, CEO of Panacea Healthcare Solutions. Whether you’re a healthcare executive, a financial professional, or simply curious about how these essential pieces of the healthcare puzzle fit together, you’re in the right place. Our goal is simple to give you actionable insights and expert perspectives that can help you optimize your operations and drive strategic growth.2025 Panacea Healthcare Solutions, LLC Politics & Government
Episodes
  • Acquisition of MedLearn

    Acquisition of MedLearn
    Feb 11 2026
    Panacea Healthcare Solutions Acquires MedLearn Media With Host Kevin Chmura, CEO of Panacea Healthcare Solutions and Guest Angela Kornegor, CEO of MedLearn Media In this episode of Beyond the Bottom Line, Kevin Chmura is joined by MedLearn Media’s CEO, Angela Kornegor, to discuss Panacea and MedLearn’s shared history, in response to Panacea’s latest acquisition of MedLearn. Kevin and Angela dive into MedLearn’s trusted education brands which include MedLearn Publishing, RACmonitor and ICD10monitor and how combining forces completes the model of software, consulting and professional level education. They explore how this will give coding, HIM and compliance teams the tools, insights and accredited education needed to keep up with complex rules while protecting revenue and focusing on patient care. Episode transcript available below. Kevin Chmura Welcome to Beyond the Bottom Line. I’m your host, Kevin Chmura, CEO of Panacea Healthcare Solutions. After eight years apart, MedLearn Media has rejoined Panacea and I couldn’t be more pleased about that and I want to share why. Today I’m sitting down with Angela Kornegor, head of MedLearn, to talk about our shared history. MedLearn’s trusted Education brands which include MedLearn Publishing, RACmonitor and ICD10monitor and how combining our forces completes the model of software, consulting and professional level education. Our goal is simple, give coding, HIM and compliance teams the tools, insights and accredited education they need to keep up with complex rules while protecting revenue and focusing on patient care. So, Angela, welcome. Welcome to Panacea. Let me be the first to welcome you to Panacea. But I guess I should do this appropriately and welcome you back to Panacea. That’s probably the way to say it, right? Ours is an interesting. History, Panacea and MedLearn. And you’re probably more qualified to talk about it than I am because you, your time spanned both the time we were one company and the time we were and now we are again. So maybe I could ask you to just give me a couple of minutes on the history for everybody that’s listening. Angela Kornegor Yeah. Well, it’s been eight years. So, it’s been eight years since MedLearn was a part of Panacea, which was great. We were together for six years. At that time, we had MedLearn Publishing, RACmonitor, ICD10monitor, which we still have, but we didn’t have the depth of content in the digital format that we have now, eight years ago. Kevin Chmura Yeah, yeah, that’s it. And so a series of M&A moves brought the company together, brought the companies together, broke them apart. And then we found our way home to each other just a month or two ago. How long has it been? Angela Kornegor It’s been a long time, but it’s just officially a month ago. Kevin Chmura Deals are hard. Deals are hard and you were great during the deal. We have said this to each other that that the deals are hard because for so many people in a deal, the day of the closing is their last day. For you and me, it’s the beginning. We were involved in the rest of it as well. You were great. So, I’m looking forward to, you know, really working with you, not just to get the deal done. So, look for the Panacea customers who are pretty, pretty tight on what we do. I thought maybe you could give me a couple of minutes on. On MedLearn, generally catch everybody up. There are those who will remember MedLearn from the past and as you just stated, you’ve evolved greatly. So, you just if you give us a couple of minutes on what you’re doing today. Angela Kornegor Absolutely, absolutely. So again, we still have our three brands. So MedLearn Publishing, RACmonitor, ICD10monitor. Our goal there is to focus on trusted deep. Content that will help with regulatory rules and all the burdensome government changes that are going on left and right to help make sure that they can A) get accredited content because that’s what they need to keep their credentials up, but we want to help make sure that they’re continuing to be the hero at what they do because it’s not an easy job, it’s tough. And these complex rules make getting their revenue, focusing on patient care a challenge. And we want them focusing on patient care because that’s what impacts all of us. Kevin Chmura Yeah, yeah, it’s interesting. You know the coding HIM in in healthcare often called mid-rev cycle and it really is it’s the core. And when you think about it’s… The core is the handoff from the clinical to the financial and that handoff is so critical and we as an industry has not. We haven’t made it easy for the folks that are professionals in that space. We don’t need to have. I spent 30 years in the back end of the revenue cycle, certainly could get credentialed in different things, but was never required to unlike coders. So, what MedLearn does is so critical to that world and we’re excited to bring it to Panacea. I think ...
    Show More Show Less
    11 mins
  • Medicaid Eligibility Under the One Big Beautiful Bill Act: Our Expert Breaks it Down

    Medicaid Eligibility Under the One Big Beautiful Bill Act: Our Expert Breaks it Down
    Jul 22 2025
    Medicaid Eligibility Under the One Big Beautiful Bill Act: Our Expert Breaks it Down With Host Kevin Chmura, CEO of Panacea Healthcare Solutions and Guest Brian Herdman, Director, Financial Reimbursement Services, KA Consulting Division In this episode of Beyond the Bottom Line, Kevin Chmura is joined by policy expert Brian Herdman to discuss how the One Big Beautiful Bill Act is set to impact Medicaid eligibility, what this critical issue means for hospitals and healthcare providers, and how these changes can affect your bottom line. Kevin and Brian dive into not only what changes providers can expect to see right away, but also those changes which will be coming into play in the next few years, and how to best prepare before they happen. They also explore what challenges hospitals can expect to see as a result of this bill’s passage, as well as if there are any positives for healthcare systems or providers. Episode transcript available below. Kevin Chmura Hi, and welcome back to Beyond the Bottom Line, Panacea’s Podcast exploring the business and policy issues that matter most to healthcare organizations. I’m your host, Kevin Chmura, CEO of Panacea Healthcare Solutions. In this follow-up episode, we’ll continue our conversation with Panacea’s policy expert, Brian Herdman, about Medicaid funding, a critical issue for hospitals and healthcare providers, and take a closer look at how the latest developments in Congress and the administration could impact your bottom line. We’ll also revisit some of the practical steps you should be thinking about today to strengthen your organization’s financial position now that we’ve seen how these policy issues have unfolded. So Brian, welcome back to the podcast. Brian Herdman Great to be here. Kevin Chmura Great to have you back. So, Brian, the One Big Beautiful Bill Act, the OBBBA has now been signed into law and we did a podcast on this topic in March, at which point we were really looking at the versions of the bill that were being kicked around. We were really probably going more off of what we were seeing in the press, in the media, and less what we really knew. Now we’re getting a real look at it. You’ve had an opportunity to spend some time with the text and do your analysis. You are by far our best regulatory expert here at Panacea, so interested in in what you’re saying now, we can spend a lot of time going through the individual provisions as they relate to Medicaid and those things that will be deeply impactful. If we went through all of them, this would be a three hour podcast and I think we lose a lot of the audience. I thought maybe what would be better for everybody, given your expertise in this area? Probably crafting it a little to our target audience, which is probably mostly hospitals and health systems, wondering if you might just spend some time talking about those provisions and those elements that you’re paying the most attention to, the things that you think will be most impactful. And maybe we just take the conversation from there. Brian Herdman Sure. Sure, Kevin. So, you know, after all that back and forth and all those, you know, 4th of July deadline to get the bill passed and whatnot, there is a lot of, you know, what’s going to stay in, what’s not going to stay in between the House and Senate reconciliation process. And now that that has shook out, you know, as I’m looking at the Medicaid specific provisions, because I think that’s where the big change is going to be for our clients, on that Medicaid provisions, you know, there’s kind of two kind of two way, two sets of issues our clients are going to have to look at, you know, the things are going to affect which specific claims are going to be eligible for Medicaid and at what amount. And just generally speaking, the environment that the state, that the provider operates in the state with the state’s Medicaid program, what’s happening with FMAP, what’s happening with state directed payments and how is that going to all unfold? So as I’m looking at those two kind of main themes, you know, what’s happening like, you know, soon what’s happening soon-ish and then, you know, what’s kind of pushed out far ahead. And when I look at the things that are coming up soon, it’s not anything that’s like, you know, hair on fire, oh, my gosh, we have to do a lot of things differently. There was that immediate elimination of some moratorium on some things that would get you streamline applications into Medicaid. That’s going away. And, you know, there is that reduction in FMAP percentage to states when they have done that expansion. But, you know, on the margins, none of those things are going to be a dramatic change to how our clients, you know, get how many of those claims go through and how much they really get paid by the state. When you really start to see that happen is around January 2027. That’s when we’ll start to see a lot of ...
    Show More Show Less
    15 mins
  • Unlocking Access: How RevenueRx Transforms Drug Assistance for Hospitals

    Unlocking Access: How RevenueRx Transforms Drug Assistance for Hospitals
    Jul 14 2025
    Unlocking Access: How RevenueRx Transforms Drug Assistance for Hospitals With Host Kevin Chmura, CEO of Panacea Healthcare Solutions and Guest BreAnn Meadows, President, Revenue Integrity Services In this episode of Beyond the Bottom Line, Kevin Chmura is joined by BreAnn Meadows to discuss Panacea’s latest healthcare solution: RevenueRx: Drug Assistance Program designed to help hospitals streamline access to free drugs, co-pay assistance, and charitable foundation support programs. Kevin and Bre delve into this new service, what it offers to hospitals, why the solution is being introduced now, and what sets RevenueRx apart from other programs. They also share specific examples of how it can deliver measurable benefits and meaningful impact for your healthcare organization. Episode transcript available below. Kevin Chmura Welcome to Beyond the Bottom Line: Let’s talk healthcare, finance, revenue cycle and compliance. I’m your host, Kevin Chmura, CEO of Panacea Healthcare Solutions. Whether you’re a healthcare executive, a finance professional, or simply curious about how these essential pieces of the healthcare puzzle fit together, you’re in the right place. The goal is simple: Give you actionable insights and expert perspectives that can help you optimize your operations and drive strategic growth. In today’s episode, we’re talking about a topic that’s becoming a real game changer for hospitals and health systems, patient drug assistance. Joining me is BreAnn Meadows, president of Revenue Integrity Services here at Panacea Healthcare Solutions. Bre and her team just launched RevenueRx, a service that’s helping hospitals streamline access to free drugs, co-pay assistance and charitable foundation support programs. Welcome, Bre. Bre Meadows Thank you. Kevin Chmura So let’s start with the basics. What is RevenueRx? And it’s probably a good place to start. And why did we decide to launch this at Panacea now? Bre Meadows So RevenueRx is a comprehensive tech enabled service that helps hospitals and cancer centers manage the manufacturer-sponsored drug programs. And then also the foundation assistance. So, as you said, we do include services based around the manufacturer free drug programs, the co-pay assistance programs, and the charitable foundation funding we launched RevenueRx because hospitals are still continuing to face growing pressures. The cost of drugs just continues to go up, and the payer policies get more and more difficult to manage, along with patients out-of-pocket and coverage determinations always being really challenging. So there’s a lot of roadblocks when a patient gets a diagnosis where they have to go to a cancer or infusion center to start one of these treatments. And the reason we launched this program is to really help hospitals clear those roadblocks so patients can get access to care without being financially destroyed by their diagnosis. So it’s a great program that really benefits the facility financially as well as the patient, to give them access to these drugs that could save their life. Kevin Chmura Wow. So real win/win, right? You’ve got better access for the patients and operational relief and revenue, most importantly, for hospitals and health systems, which is great. It’s always nice when everybody gets a win out of it. So great rundown on the on the benefits of it. But can you walk us through what is the actual deliverable of RevenueRx? Bre Meadows Sure. So RevenueRx is almost set up a little bit differently than some other services that are out there that even though we’re technical, we still really focus on the service and really working closely with the organization and their patients. So what we manage is everything, soup-to-nuts, starting with the application process. So we do all the screening of patients looking for all the programs that the patient could qualify for, completing the application and making sure the patients get approved for not just the primary drug that they may be receiving for that service, but any and all drugs to minimize their out-of-pocket as much as possible. The second piece that we do is making sure that after the application is approved, that everything gets followed through on behalf of the patient and the organization. So when we talk about “free drug,” we handle the ordering and try to get everything ordered as prospectively as possible. And we could talk a little bit more in depth about the advantages of that and billing compliance, but making sure that also the patient has confidence as they’re coming in for these visits. They know that we’ve taken care of it. They know their drug is sitting there waiting for them and that they’re not going to be getting a bill after they leave the center. And then the third part is on the co-pay and foundation programs. Again, after a patient is approved, we do all the tracking to make sure that the funds get loaded for the patient and then make it...
    Show More Show Less
    14 mins
No reviews yet